Patent №
US 9,504,664
Granted
2016-11-29
Filed 2015
Owner
BIOCOPEA LIMITED
+2 more
Lab
—
AI components
1
nlp
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
14975599
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
Natural languageA61K 31/192A61F 5/026A61K 9/0014A61K 9/0019A61K 9/0053A61K 9/06A61K 9/08A61K 9/2013+18 more
AI classification
Natural language0.98
Planning0.02
AI hardware0.02
Machine learning0.00
Evolutionary computation0.00
Knowledge representation0.00
Speech0.00
Vision0.00
Ownership
BIOCOPEA LIMITED
assignment · 384300407
IMMUNOCOPEA LIMITED
assignment · 384300475
INFIRST HEALTHCARE LIMITED
assignment · 384300492
Assignors
BIOCOPEA LIMITED
On an employer assignment, the assignors are typically the inventors.
From the same owner
Solid Solution Compositions and Use in Chronic InflammationUS 11,844,773 · 2023Compositions and Methods for Treating Severe PainUS 11,730,709 · 2023Compositions and Methods for Treating Chronic Inflammation and Inflammatory DiseasesUS 11,660,276 · 2023Solid Solution Compositions and Use in Cardiovascular DiseaseUS 11,202,831 · 2021Solid Solution Compositions and Use in Chronic InflammationUS 11,154,500 · 2021Compositions and Methods for Treating Chronic Inflammation and Inflammatory DiseasesUS 11,065,218 · 2021Solid Solution Compositions and Use in Chronic InflammationUS 11,000,493 · 2021Compositions and Methods for Treating Severe PainUS 10,857,114 · 2020